Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jesus F. San Miguel"'
Autor:
Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, Anastasiia Zherniakova, Camila Guerrero, Aintzane Zabaleta, Leire Burgos, Cirino Botta, Maria-Antonia Fortuño, Carlos Grande, Andrea Manubens, Jose-Maria Arguiñano, Clara Gomez, Ernesto Perez-Persona, Iñigo Olazabal, Itziar Oiartzabal, Carlos Panizo, Felipe Prosper, Jesus F. San-Miguel, Paula Rodriguez-Otero, Esperanza Martín-Sánchez, Bruno Paiva, The Asociación Vasco-Navarra de Hematología y Hemoterapia (ASOVASNA) Cooperative Group
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-13 (2021)
Blood Cancer Journal
Blood Cancer Journal
There is evidence of reduced SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. We hypothesized that tumor and treatment-related immunosuppression can be depicted in peripheral blood, and that immune profiling prior to vacc
Autor:
José A. Pérez-Simón, Ignacio García Escobar, Maria V. Mateos Manteca, Dolores Caballero Barrigón, Jesus F. San Miguel Izquierdo, Pilar Tamayo Alonso
Publikováno v:
Annals of Nuclear Medicine. 22:251-260
In the present study, we evaluated computed tomography (CT) and (67)gallium scanning ((67)Ga scan) pre-transplant as prognostic factors for overall survival (OS) and event-free survival (EFS) in patients with diffuse large B cell lymphoma, undergoing
Autor:
Alejandro, Martín, Josè Antonio, Pérez-Simón, Maria Dolores, Caballero, Natalia, López-Holgado, Lourdes, Vázquez, Maria Consuelo, del Cañizo, Jesus F, San Miguel
Publikováno v:
Haematologica. 90(1)
It has recently been demonstrated that autologous bone-marrow transplantation (ABMT) is feasible in heavily pretreated patients who do not mobilize peripheral blood progenitor cells (PBPC), suggesting that bone marrow (BM) progenitor-cells are not as
Autor:
Clara, Bueno, Julia, Almeida, Paulo, Lucio, Josefa, Marco, Raimundo, Garcia, Jose Maria, de Pablos, Antonio, Parreira, Fernando, Ramos, Francisco, Ruiz-Cabello, Dimas, Suarez-Vilela, Jesus F, San Miguel, Alberto, Orfao
Publikováno v:
Haematologica. 89(1)
Recent reports suggest that CD4(+)/CD56(+)/lineage(-) hematopoietic neoplasias are aggressive types of malignancies involving lymphoplasmacytoid/DC2 dendritic cells (DC). Here, we report on the incidence of DC malignancies and their clinical, biologi
Autor:
José, Rodriguez, Maria Dolores, Caballero, Antonio, Gutierrez, Marco, Gandarillas, Jorge, Sierra, Armando, Lopez-Guillermo, Anna, Sureda, Javier, Zuazu, Jesus, Marin, Reyes, Arranz, Enric, Carreras, Angel, Leon, Alberto Fernández, De Sevilla, Jesus F, San Miguel, Eulogio, Conde
Publikováno v:
Haematologica. 88(12)
Patients with aggressive non-Hodgkin's lymphomas (NHL) who do not obtain a complete response (CR) after induction chemotherapy have a poor prognosis. However, provided they are sensitive to the first regimen of chemotherapy, 25-40% of them with a B-c
Autor:
Pablo, Menéndez, Jose A, Pérez-Simón, Maria V, Mateos, Maria D, Caballero, Marcos, González, Jesus F, San-Miguel, Alberto, Orfao
Publikováno v:
British journal of haematology. 119(1)
Currently, no information is available regarding the influence of the different CD34+ cell subsets infused on the haematopoietic recovery, following non-myeloablative allogeneic peripheral blood stem cell transplantation (allo-PBSCT). We have explore